NCT04544722

Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD

Clinical Study of Jianfei Kangfu Cao in the Treatment of Primary Sjogren's Syndrome Associated Interstitial Lung Disease.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 138 (estimated)
• Sponsor: Shanghai University of Traditional Chinese Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of Jianfei Kangfu Cao in the treatment of primary Sjogren's syndrome associated interstitial lung disease.

Detailed description

This study will be a randomized, double-blind, positive control clinical trial with a course of 24 weeks. 1. Random scheme:the DAS for Interactive Web Response System(IWRS) will be used to calculate and distribute random numbers and dispensing drugs. 2. Blind method ：The test process will be in a double-blind state. 3. Control drug: The lung rehabilitation training will be used as control in this trial.

Conditions

• Primary Sjogren's Syndrome
• Interstitial Lung Disease

Interventions

Type	Name	Description
BEHAVIORAL	Jianfei Kangfu Cao	The original treatment and Jianfei Kangfu Cao, once a day, 30 minutes each time.
BEHAVIORAL	lung rehabilitation training	The original treatment and the lung rehabilitation training, once a day, 30 minutes each time.

Timeline

• Start date: 2020-10-01
• Primary completion: 2022-09-01
• Completion: 2023-06-01
• First posted: 2020-09-10
• Last updated: 2021-03-01

Locations

1 site across 1 country: China